Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 36,749 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 36,749 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $655,602.16. Following the transaction, the president directly owned 1,058,813 shares in the company, valued at $18,889,223.92. The trade was a 3.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.48, for a total transaction of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total value of $508,021.85.
• On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.63, for a total value of $618,900.00.
• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $22.48, for a total value of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total transaction of $5,285,991.80.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $18.16 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The stock has a market capitalization of $3.71 billion, a PE ratio of -1,814.19, a price-to-earnings-growth ratio of 2.66 and a beta of 1.18. The company has a 50 day moving average price of $20.51 and a two-hundred day moving average price of $18.78. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. During the same quarter in the prior year, the business posted ($0.16) EPS. Alignment Healthcare’s quarterly revenue was up 44.4% on a year-over-year basis. As a group, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently made changes to their positions in the business. Royal Bank of Canada boosted its stake in Alignment Healthcare by 92.6% during the 1st quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock valued at $1,720,000 after purchasing an additional 44,413 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Alignment Healthcare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after buying an additional 2,594 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Alignment Healthcare by 79.1% during the first quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after buying an additional 429,703 shares during the last quarter. Woodline Partners LP acquired a new position in shares of Alignment Healthcare during the first quarter worth approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Alignment Healthcare by 16.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after acquiring an additional 44,452 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Neutral Sentiment: Analyst comparison article — a Zacks piece compares ALHC to BrightSpring (BTSG) for value-oriented investors; useful for context but not an immediate catalyst. BTSG or ALHC: Which Is the Better Value Stock Right Now?
• Neutral Sentiment: Short-interest report appears to contain errors (reports 0 shares and “NaN” increases). The published data is not meaningful — do not treat it as evidence of rising short pressure until corrected by exchanges/brokers.
• Negative Sentiment: CEO John E. Kao sold 73,046 shares at an average $17.84 for ~$1.30M on Mar 18; his ownership fell ~3.93%. Filing: SEC Filing
• Negative Sentiment: President Dawn C. Maroney sold 36,749 shares at $17.84 (~$655.6k) on Mar 18; her stake dropped ~3.35%. Filing: SEC Filing
• Negative Sentiment: Insider Christopher J. Joyce sold 25,125 shares at $17.84 (~$448.2k) on Mar 18; his position fell ~7.21%. Filing: SEC Filing
• Negative Sentiment: Hyong Kim sold 18,404 shares at $17.84 (~$328.3k) on Mar 18; his holding declined ~4.77%. Filing: SEC Filing
• Negative Sentiment: COO Sebastian Burzacchi sold 15,361 shares at $17.84 (~$274.0k) on Mar 18; his stake fell ~5.61%. Filing: SEC Filing
• Negative Sentiment: Andreas P. Wagner executed two recent sales (12,000 @ $17.84 on Mar 18 and 11,602 @ $18.22 on Mar 19), ~23.6k shares total for ~ $425.5k, reducing his stake ~7%. Filing: SEC Filing
• Negative Sentiment: Robert L. Scavo sold 11,285 shares at $17.84 (~$201.3k) on Mar 18; his position dipped ~2.26%. Filing: SEC Filing

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. KeyCorp reiterated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, March 7th. Piper Sandler upped their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 6th. UBS Group increased their price target on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, January 14th. Finally, Robert W. Baird set a $28.00 price target on shares of Alignment Healthcare in a research report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $24.56.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.